Foghorn Therapeutics Inc (NASDAQ:FHTX) price on Thursday, July 03, rose 3.64% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $5.13.
A look at the stock’s price movement, the close in the last trading session was $4.95, moving within a range at $4.96 and $5.17. The beta value (5-Year monthly) was 3.046. Turning to its 52-week performance, $10.25 and $2.94 were the 52-week high and 52-week low respectively. Overall, FHTX moved 17.66% over the past month.
Foghorn Therapeutics Inc’s market cap currently stands at around $285.95 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that FHTX is a 50% Buy. On the other hand, the stock is on average a Hold as suggested by medium term indicators while long term indicators are putting the stock in Hold category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 2 recommend FHTX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
FHTX’s current price about 9.27% and 16.06% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 65.68, while 7-day volatility ratio is 7.37% and 6.95% in the 30-day chart. Further, Foghorn Therapeutics Inc (FHTX) has a beta value of 3.05. Analysts have given the company’s stock an average 52-week price target of $16.5, forecast between a low of $9 and high of $20. Looking at the price targets, the low is -75.44% off current price level while to achieve the yearly target high, price needs to move -289.86%. Nonetheless, investors will most likely welcome a -221.64% jump to $16.5 which is the analysts’ median price.
If we refocus on Foghorn Therapeutics Inc (NASDAQ:FHTX), historical trading data shows that trading volumes averaged 0.18 over the past 10 days and 135.27K over the past 3 months. The company’s latest data on shares outstanding shows there are 55.72 million shares.
The 49.95% of Foghorn Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 41.82% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.47 million on 2025-06-13, giving us a short ratio of 13.11. The data shows that as of 2025-06-13 short interest in Foghorn Therapeutics Inc (FHTX) stood at 401.0 of shares outstanding, with shares short rising to 1.07 million registered in 2025-05-15. Current price change has pushed the stock -12.16% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the FHTX stock continues to rise going into the next quarter.
